These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8866418)

  • 1. Performance characteristics of a dialysis-related amyloidosis questionnaire.
    Chertow GM; Trimbur T; Karlson EW; Lazarus JM; Kay J
    J Am Soc Nephrol; 1996 Aug; 7(8):1235-40. PubMed ID: 8866418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 2-microglobulin-related amyloidosis in patients receiving chronic hemodialysis.
    Gejyo F; Homma N; Maruyama H; Arakawa M
    Contrib Nephrol; 1988; 68():263-9. PubMed ID: 3069321
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical staging score to measure the severity of dialysis-related amyloidosis.
    Hoshino J; Kawada M; Imafuku A; Mise K; Sumida K; Hiramatsu R; Hasegawa E; Hayami N; Yamanouchi M; Suwabe T; Sawa N; Ubara Y; Takaichi K
    Clin Exp Nephrol; 2017 Apr; 21(2):300-306. PubMed ID: 27339443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of dialysis-related amyloidosis: focusing on carpal tunnel syndrome].
    Nishi S
    Brain Nerve; 2014 Jul; 66(7):783-93. PubMed ID: 24998823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of dialysis-related amyloidosis with lower quality of life in patients undergoing hemodialysis for more than 10 years: The Kyushu Dialysis-Related Amyloidosis Study.
    Tsuruya K; Arima H; Iseki K; Hirakata H;
    PLoS One; 2021; 16(8):e0256421. PubMed ID: 34428227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?
    Schwalbe S; Holzhauer M; Schaeffer J; Galanski M; Koch KM; Floege J
    Kidney Int; 1997 Oct; 52(4):1077-83. PubMed ID: 9328948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis amyloidosis: current disease concepts and new perspectives for its treatment.
    Gejyo F; Arakawa M
    Contrib Nephrol; 1990; 78():47-59; discussion 59-60. PubMed ID: 2225843
    [No Abstract]   [Full Text] [Related]  

  • 9. Carpal tunnel syndrome and beta 2-microglobulin-related amyloidosis in chronic hemodialysis patients.
    Gejyo F; Homma N; Arakawa M
    Blood Purif; 1988; 6(2):125-31. PubMed ID: 3293616
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.
    Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
    Nephrol Dial Transplant; 2016 Apr; 31(4):595-602. PubMed ID: 26206763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological survey and risk factor analysis of dialysis-related amyloidosis including destructive spondyloarthropathy, dialysis amyloid arthropathy, and carpal tunnel syndrome.
    Tagami A; Tomita M; Adachi S; Tsuda K; Yamada S; Chiba K; Okazaki N; Yonekura A; Tsujimoto R; Kajiyama S; Matsubayashi S; Miyamoto T; Mochizuki Y; Ohba K; Osaki M
    J Bone Miner Metab; 2020 Jan; 38(1):78-85. PubMed ID: 31414282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis-related amyloidosis: history and clinical manifestations.
    Danesh F; Ho LT
    Semin Dial; 2001; 14(2):80-5. PubMed ID: 11264771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
    Schiffl H
    Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic involvement of dialysis-amyloidosis.
    Campistol JM; Solé M; Muñoz-Gomez J; Lopez-Pedret J; Revert L
    Am J Nephrol; 1990; 10(5):389-96. PubMed ID: 2080789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J; Floege J; Ehlerding G; Koch KM
    Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphology and diagnosis of hemodialysis--related amyloidosis].
    Ohashi K; Kawai R; Hara M
    Nihon Rinsho; 1992 Jan; 50 Suppl():801-6. PubMed ID: 1578770
    [No Abstract]   [Full Text] [Related]  

  • 18. Dialysis-associated amyloidosis.
    Sethi D
    Ren Fail; 1993; 15(3):349-51. PubMed ID: 8516489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloidosis in chronic hemodialysis: rheumatological aspects.
    Bouteiller G; Ton That H; Goudable C; Goffinet F; Heche JP; Orfila C; Suc JM
    Contrib Nephrol; 1988; 62():67-74. PubMed ID: 3282800
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.